{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:07:53Z","timestamp":1758892073178},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:00Z","timestamp":1426377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00535-015-1063-2","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T22:56:24Z","timestamp":1426287384000},"page":"1134-1144","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma"],"prefix":"10.1007","volume":"50","author":[{"name":"The Hepatitis Glyco-biomarker Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujiyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moto","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Korenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jamcollsurg.2007.01.035","volume":"204","author":"A Taketomi","year":"2007","unstructured":"Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute\u2019s experience with 625 patients. J Am Coll Surg. 2007;204:580\u20137.","journal-title":"J Am Coll Surg"},{"key":"1063_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jamcollsurg.2010.06.005","volume":"211","author":"T Kamiyama","year":"2010","unstructured":"Kamiyama T, Nakanishi K, Yokoo H, et al. Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg. 2010;211:443\u20139.","journal-title":"J Am Coll Surg"},{"key":"1063_CR3","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1007\/s00268-010-0655-5","volume":"34","author":"P Gassmann","year":"2010","unstructured":"Gassmann P, Spieker T, Haier J, et al. Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg. 2010;34:2442\u201351.","journal-title":"World J Surg"},{"key":"1063_CR4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11605-013-2423-y","volume":"18","author":"K Fukushima","year":"2014","unstructured":"Fukushima K, Fukumoto T, Kuramitsu K, et al. Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg. 2014;18:729\u201336.","journal-title":"J Gastrointest Surg"},{"key":"1063_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.0007-1323.2001.01969.x","volume":"89","author":"S Ko","year":"2002","unstructured":"Ko S, Kanehiro H, Hisanaga M, et al. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg. 2002;89:57\u201362.","journal-title":"Br J Surg"},{"key":"1063_CR6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","volume":"142","author":"L Castera","year":"2012","unstructured":"Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142:1293\u2013302.","journal-title":"Gastroenterology"},{"issue":"140","key":"1063_CR7","first-page":"1970","volume":"2011","author":"J Vergniol","year":"1979","unstructured":"Vergniol J, Foucher J, Terrebonne E, et al. Noninvasive tests for fibrosis and liver stiffness predict 5\u00a0year outcomes of patients with chronic hepatitis C. Gastroenterology. 1979;2011(140):1970\u20139.","journal-title":"Gastroenterology"},{"key":"1063_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00535-010-0365-7","volume":"46","author":"T Toshima","year":"2011","unstructured":"Toshima T, Shirabe K, Takeishi K, et al. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705\u201311.","journal-title":"J Gastroenterol"},{"key":"1063_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.","journal-title":"Sci Rep"},{"key":"1063_CR10","doi-asserted-by":"crossref","unstructured":"Kuno A, Sato T, Shimazaki H, et al. Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin Appl. 2013;7:642\u2013647.","DOI":"10.1002\/prca.201300010"},{"key":"1063_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0168-8278(96)80076-6","volume":"25","author":"M Artini","year":"1996","unstructured":"Artini M, Natoli C, Tinari N, et al. Elevated serum levels of 90K\/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol. 1996;25:212\u20137.","journal-title":"J Hepatol"},{"key":"1063_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2893.2009.01083.x","volume":"16","author":"KJ Cheung","year":"2009","unstructured":"Cheung KJ, Tilleman K, Deforce D, et al. The HCV serum proteome: a search for fibrosis protein markers. J Viral Hepat. 2009;16:418\u201329.","journal-title":"J Viral Hepat"},{"key":"1063_CR13","doi-asserted-by":"crossref","first-page":"14245","DOI":"10.1016\/S0021-9258(19)85233-X","volume":"268","author":"K Koths","year":"1993","unstructured":"Koths K, Taylor E, Halenbeck R, et al. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem. 1993;268:14245\u20139.","journal-title":"J Biol Chem"},{"key":"1063_CR14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","volume":"17","author":"T Sasaki","year":"1998","unstructured":"Sasaki T, Brakebusch C, Engel J, et al. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998;17:1606\u201313.","journal-title":"EMBO J"},{"key":"1063_CR15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1006\/jmbi.1999.2996","volume":"291","author":"SA M\u00fcller","year":"1999","unstructured":"M\u00fcller SA, Sasaki T, Bork P, et al. Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structures. J Mol Biol. 1999;291:801\u201313.","journal-title":"J Mol Biol"},{"key":"1063_CR16","author":"M Abe","year":"2014","unstructured":"Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol. 2014. doi: 10.1007\/s00535-014-1007-2 .","journal-title":"J Gastroenterol"},{"key":"1063_CR17","author":"T Toshima","year":"2014","unstructured":"Toshima T, Shirabe K, Ikegami T, et al. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis. J Gastroenterol. 2014. doi: 10.1007\/s00535-014-0946-y .","journal-title":"J Gastroenterol"},{"key":"1063_CR18","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","volume":"60","author":"K Yamasaki","year":"2014","unstructured":"Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563\u201370.","journal-title":"Hepatology"},{"key":"1063_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0928-4346(96)00325-8","volume":"6","author":"F Ichida","year":"1996","unstructured":"Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6:112\u20139.","journal-title":"Int Hepatol Commun"},{"key":"1063_CR20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology"},{"key":"1063_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1477-7819-10-107","volume":"10","author":"T Kamiyama","year":"2012","unstructured":"Kamiyama T, Nakanishi K, Yokoo H, et al. Analysis of the risk factors for early death due to disease recurrence or progression within 1\u00a0year after hepatectomy in patients with hepatocellular carcinoma. World J Surg Oncol. 2012;10:107.","journal-title":"World J Surg Oncol"},{"key":"1063_CR22","doi-asserted-by":"crossref","first-page":"18401","DOI":"10.1016\/S0021-9258(17)32322-0","volume":"269","author":"A Ullrich","year":"1994","unstructured":"Ullrich A, Sures I, D\u2019Egidio M, et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem. 1994;269:18401\u20137.","journal-title":"J Biol Chem"},{"key":"1063_CR23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4049\/jimmunol.128.3.1221","volume":"128","author":"MK Ho","year":"1982","unstructured":"Ho MK, Springer TA. Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol. 1982;128:1221\u20138.","journal-title":"J Immunol"},{"key":"1063_CR24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23654","volume":"52","author":"A Matsuda","year":"2010","unstructured":"Matsuda A, Kuno A, Kawamoto T, et al. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology. 2010;52:174\u201382.","journal-title":"Hepatology"},{"key":"1063_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2013.04.017","volume":"85","author":"A Matsuda","year":"2013","unstructured":"Matsuda A, Kuno A, Matsuzaki H, et al. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. J Proteomics. 2013;85:1\u201311.","journal-title":"J Proteomics."},{"key":"1063_CR26","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/pr400986t","volume":"13","author":"M Ocho","year":"2014","unstructured":"Ocho M, Togayachi A, Iio E, et al. Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis. J Proteome Res. 2014;13:1428\u201337.","journal-title":"J Proteome Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-015-1063-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1063-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T16:09:56Z","timestamp":1691510996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-015-1063-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s00535-015-1063-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2015,3,15]]}}}